A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing; to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

H.R. 4299 — A bill to amend the Controlled Substances Act with respect to drug scheduling recommendations by the Secretary of Health and Human Services, and with respect to registration of manufacturers and distributors seeking to conduct clinical testing; to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

By Mr. PITTS (for himself and Mr. Pallone), H2694 [26MR]

Cosponsors added, H2803 [1AP], H2915 [3AP], H3058 [8AP], H3144 [9AP], H3199 [10AP], H3293 [29AP], H4476 [19MY], H4686 [20MY], H4911 [28MY], H5024 [29MY], H7297 [8SE]

Reported from the Committee on Energy and Commerce (H. Rept. 113–565, part 1), H7038 [29JY]

Referral to the Committee on the Judiciary extended, H7039 [29JY]

Reported with amendment from the Committee on the Judiciary (H. Rept. 113–565, part 2), H7900 [19SE]